Firm's AR E-Commerce Solutions to Be Marketed, Sold to Dispensaries
Source: Streetwise Reports  (4/29/19)
With the signing of a reseller agreement, the tech firm continues to penetrate Canada's burgeoning legal cannabis industry. More >

'Undervalued' Biopharma Features Robust Pipeline, Future Upside
Source: Streetwise Reports  (4/24/19)
The case for investing in this company was made in an H.C. Wainwright & Co. report. More >

Health Tech Firm to Pilot Artificial Intelligence-Powered Patient Monitoring Tool
Source: Streetwise Reports  (4/24/19)
This effort is one way the company can innovatively offer patients care. More >

California Gold Mining Full Speed Ahead in Hemp
Source: Peter Epstein for Streetwise Reports  (4/18/19)
Peter Epstein of Epstein Research provides an update on a mining exploration company that is diversifying into the hemp market. More >

Health Technology Firm Aims to Extend Reach into Global Medical Cannabis Industry
Source: Streetwise Reports  (4/17/19)
This company is targeting geographies where the cannabis market is growing rapidly. More >

Analyst: Biopharma, Now Stronger Than Ever, Is an Ideal Takeout Target
Source: Streetwise Reports  (4/17/19)
An argument is made in a ROTH Capital Partners report for a potential imminent deal involving this drug maker. More >

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial
Source: Streetwise Reports  (4/17/19)
Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. More >

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease
Source: Streetwise Reports  (4/10/19)
Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. More >

Augmented Reality Firm Moves into Medical Devices Arena
Source: Streetwise Reports  (4/9/19)
This technology company continues to diversify the end markets for its e-commerce platform. More >

Canadian Tech Firm Secures Largest Contract to Date
Source: Streetwise Reports  (4/6/19)
The new client, in the U.S., is a state governmental agency. More >

Biotech Achieves Development Milestone for Blue Light Imaging System
Source: Streetwise Reports  (4/5/19)
The surgical imaging firm continues to advance its first medical device toward commercialization. More >

Canadian Life Sciences Firm Seeks Collaborative Cannabis Partner
Source: Streetwise Reports  (4/5/19)
This represents the company's expansion into another business area. More >

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies
Source: Streetwise Reports  (4/3/19)
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. More >

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19
Source: Streetwise Reports  (4/3/19)
Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report. More >

CBD Firm Tallies Strong Q4/18 Performance, 2019 Outlook
Source: Streetwise Reports  (4/3/19)
A ROTH Capital Partners report reviewed the numbers for 2018 and explained why this Colorado-based company should perform well this year. More >

Cannabis Beverages, Edibles Company Receives Key Permit
Source: Streetwise Reports  (4/3/19)
This represents a major milestone for the firm on its path to commercializing its products. More >

Best-of-Breed Hemp/CBD Producers
Source: Fincom Investment Partners for Streetwise Reports  (4/2/19)
Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed." More >

Biopharma Hits Milestone in Starting Enrollment for NASH Clinical Trial
Source: Streetwise Reports  (3/30/19)
The company will discuss the trial when it hosts a conference call about this specific disease indication in April. More >

Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States
Source: Streetwise Reports  (3/30/19)
With this development, the Canadian company further expands its U.S. footprint. More >

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer
Source: Streetwise Reports  (3/30/19)
The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. More >

California Gold Entering High-CBD Content Hemp Seed Market in the U.S.
Source: Peter Epstein for Streetwise Reports  (3/28/19)
Peter Epstein of Epstein Research profiles a gold company that plans to grow hemp seed on its land. More >

Premier Health Group Adding Medical Cannabis Support Tool
Source: Streetwise Reports  (3/27/19)
This clinical decision support software integration is the first of its kind, according to the company. More >

San Diego Biopharma Features 'Strong and Balanced Pipeline'
Source: Streetwise Reports  (3/26/19)
An H.C. Wainwright & Co. report discussed what sets this company's asset apart from similar products. More >

Dosing Begins for California Biopharma's Proof-of-Concept Trial in Plaque Psoriasis
Source: Streetwise Reports  (3/25/19)
This U.S. study follows encouraging results from a Phase 1b trial in the same indication in Australia. More >

Biotech Stresses Need to Target Only Toxic Oligomer in Alzheimer's Therapies
Source: Streetwise Reports  (3/25/19)
The company cites the recent discontinuation of other firms' clinical programs as proof. More >